Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy

Rituximab, a chimeric monoclonal antibody directed against CD20, has become a part of the standard therapy for patients with non-Hodgkin's lymphoma either in combination with other drugs or as a single agent. The CD20 antigen is expressed on 95% of B-cell lymphoma cells and normal B-cells but,...

Full description

Saved in:
Bibliographic Details
Main Authors: Lee, Yuna, Kyung, Sun Young, Choi, Soo Jin, Bang, Soo-Mee, Jeong, Seong Hwan, Shin, Dong Bok, Lee, Jae Hoon
Format: Artigo
Language:Inglês
Published: The Korean Association of Internal Medicine 2006
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890722/
https://ncbi.nlm.nih.gov/pubmed/17017668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.3.183
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items